During the past decade, Associated Retinal Consultants conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 5 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Associated Retinal Consultants" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Apellis Pharmaceuticals, Inc." with 4 trials sponsored, "Lux Biosciences, Inc." with 3 trials sponsored, "Clearside Biomedical, Inc." with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Associated Retinal Consultants" #1 collaborator was "Allergan" with 1 trials as a collaborator and "National Eye Institute (NEI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Associated Retinal Consultants" are "Diabetic Macular Edema" (4 trials), "Geographic Atrophy" (3 trials), "Panuveitis" (3 trials), "Macular Degeneration" (2 trials) and "Neovascular Age-Related Macular Degeneration" (2 trials). Many other conditions were trialed in "Associated Retinal Consultants" in a lesser frequency.

Most popular intervention types in "Associated Retinal Consultants" are "Drug" (18 trials), "Other" (5 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (7 trials), "Faricimab" (4 trials), "LX211" (3 trials), "Placebo" (3 trials) and "APL-2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Associated Retinal Consultants" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Associated Retinal Consultants". undefined are not yet recruiting, 1 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Associated Retinal Consultants, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Associated Retinal Consultants, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".